The Long-Term Effectiveness and Safety of Omalizumab on Patient- and Physician-Reported Asthma Control: A Three-Year, Real-Life Observational Study
Crossref DOI link: https://doi.org/10.1007/s12325-019-01135-w
Published Online: 2019-11-18
Published Print: 2020-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Schreiber, Jens
Schwab Sauerbeck, Inessa
Mailänder, Claudia
Funding for this research was provided by:
Novartis Pharma
Text and Data Mining valid from 2019-11-18
Version of Record valid from 2019-11-18
Article History
Received: 18 September 2019
First Online: 18 November 2019